Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring

Robust evidence of fetal programming of adult disease has surfaced in the last several decades. Human and preclinical investigations of intrauterine insults report perturbations in placental nutrient sensing by the mechanistic target of rapamycin (mTOR). This review focuses on pregnancy complication...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Megan Beetch, Emilyn U. Alejandro
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/8c198d0bb2b54951a6a56c50b8475bc9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8c198d0bb2b54951a6a56c50b8475bc9
record_format dspace
spelling oai:doaj.org-article:8c198d0bb2b54951a6a56c50b8475bc92021-11-25T17:14:03ZPlacental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring10.3390/children81109702227-9067https://doaj.org/article/8c198d0bb2b54951a6a56c50b8475bc92021-10-01T00:00:00Zhttps://www.mdpi.com/2227-9067/8/11/970https://doaj.org/toc/2227-9067Robust evidence of fetal programming of adult disease has surfaced in the last several decades. Human and preclinical investigations of intrauterine insults report perturbations in placental nutrient sensing by the mechanistic target of rapamycin (mTOR). This review focuses on pregnancy complications associated with placental mTOR regulation, such as fetal growth restriction (FGR), fetal overgrowth, gestational diabetes mellitus (GDM), polycystic ovarian syndrome (PCOS), maternal nutrient restriction (MNR), preeclampsia (PE), maternal smoking, and related effects on offspring birthweight. The link between mTOR-associated birthweight outcomes and offspring metabolic health trajectory with a focus on sexual dimorphism are discussed. Both human physiology and animal models are summarized to facilitate in depth understanding. GDM, PCOS and fetal overgrowth are associated with increased placental mTOR, whereas FGR, MNR and maternal smoking are linked to decreased placental mTOR activity. Generally, birth weight is reduced in complications with decreased mTOR (i.e., FGR, MNR, maternal smoking) and higher with increased mTOR (GDM, PCOS). Offspring display obesity or a higher body mass index in childhood and adulthood, impaired glucose and insulin tolerance in adulthood, and deficiencies in pancreatic beta-cell mass and function compared to offspring from uncomplicated pregnancies. Defining causal players in the fetal programming of offspring metabolic health across the lifespan will aid in stopping the vicious cycle of obesity and type II diabetes.Megan BeetchEmilyn U. AlejandroMDPI AGarticlemTOR signalingplacentapregnancyfetal growth restrictionbirth weightobesityPediatricsRJ1-570ENChildren, Vol 8, Iss 970, p 970 (2021)
institution DOAJ
collection DOAJ
language EN
topic mTOR signaling
placenta
pregnancy
fetal growth restriction
birth weight
obesity
Pediatrics
RJ1-570
spellingShingle mTOR signaling
placenta
pregnancy
fetal growth restriction
birth weight
obesity
Pediatrics
RJ1-570
Megan Beetch
Emilyn U. Alejandro
Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
description Robust evidence of fetal programming of adult disease has surfaced in the last several decades. Human and preclinical investigations of intrauterine insults report perturbations in placental nutrient sensing by the mechanistic target of rapamycin (mTOR). This review focuses on pregnancy complications associated with placental mTOR regulation, such as fetal growth restriction (FGR), fetal overgrowth, gestational diabetes mellitus (GDM), polycystic ovarian syndrome (PCOS), maternal nutrient restriction (MNR), preeclampsia (PE), maternal smoking, and related effects on offspring birthweight. The link between mTOR-associated birthweight outcomes and offspring metabolic health trajectory with a focus on sexual dimorphism are discussed. Both human physiology and animal models are summarized to facilitate in depth understanding. GDM, PCOS and fetal overgrowth are associated with increased placental mTOR, whereas FGR, MNR and maternal smoking are linked to decreased placental mTOR activity. Generally, birth weight is reduced in complications with decreased mTOR (i.e., FGR, MNR, maternal smoking) and higher with increased mTOR (GDM, PCOS). Offspring display obesity or a higher body mass index in childhood and adulthood, impaired glucose and insulin tolerance in adulthood, and deficiencies in pancreatic beta-cell mass and function compared to offspring from uncomplicated pregnancies. Defining causal players in the fetal programming of offspring metabolic health across the lifespan will aid in stopping the vicious cycle of obesity and type II diabetes.
format article
author Megan Beetch
Emilyn U. Alejandro
author_facet Megan Beetch
Emilyn U. Alejandro
author_sort Megan Beetch
title Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
title_short Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
title_full Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
title_fullStr Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
title_full_unstemmed Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
title_sort placental mtor signaling and sexual dimorphism in metabolic health across the lifespan of offspring
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/8c198d0bb2b54951a6a56c50b8475bc9
work_keys_str_mv AT meganbeetch placentalmtorsignalingandsexualdimorphisminmetabolichealthacrossthelifespanofoffspring
AT emilynualejandro placentalmtorsignalingandsexualdimorphisminmetabolichealthacrossthelifespanofoffspring
_version_ 1718412602256654336